Trump urges judge not to fast-track his lawsuit over House subpoena


By Jan Wolfe

(Reuters) - U.S. President Donald Trump on Monday objected to a judge's plan to fast-track his lawsuit seeking to block a congressional subpoena for information about eight years of his personal and business finances.

U.S. District Judge Amit Mehta in Washington proposed holding a trial on Tuesday, May 14, but Trump's lawyers said that plan would deny the president a "full and fair" hearing.

Trump's lawyers said the hearing should only deal with his request for a preliminary ruling.

Mehta will decide whether Mazars LLP, Trump's long-time accounting firm, must comply with a subpoena issued by the House Oversight Committee seeking financial records for Trump and his company.

The committee says it needs Trump's records to examine whether he has conflicts of interest or broke the law by not disentangling himself from his business holdings as previous presidents did.

Lawyers for Trump and the Trump Organization, his company, last month filed a lawsuit to block the House Oversight subpoena, saying it exceeded the constitutional limits of Congress's investigative power.

Trump argued that, rather than fulfilling its constitutional lawmaking duties, Congress was on a quest to "turn up something that Democrats can use as a political tool against the president now and in the 2020 election."

In Monday's court filing, Trump's lawyers said they need more time to collect evidence and develop their cases, and that his right to due process would be undermined by the judge's accelerated timetable.

Democrats have confronted the Republican president and his administration for refusing to cooperate with at least six separate congressional investigations of Trump, his turbulent presidency, his family and his business interests.

Lisa Kern Griffin, a professor of constitutional law at Duke University, said Trump's strategy has been to stall the probes, so Mehta's eagerness to move quickly would likely be welcomed by Democratic lawmakers.

"The executive branch strategy mostly seems to be a blanket rejection of all attempts at oversight, regardless of the issue, up until the election," Griffin said. "So any time the calendar is accelerated that probably favors Congress."

(Reporting by Jan Wolfe; Editing by Dan Grebler and Meredith Mazzilli)


More Related News

Trump aide Conway will not testify before Congress: White House
Trump aide Conway will not testify before Congress: White House
  • US
  • 2019-06-25 01:07:22Z

President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of the Hatch Act, the White House told the panel's chairman on Monday. "In accordance with long-standing precedent, we respectfully decline the invitation to make Ms. Conway available for testimony before the Committee," White House legal counsel Pat Cipollone told Democratic Representative Elijah Cummings in a letter. The Oversight Committee has said it would vote on a potential subpoena if Conway does not testify before lawmakers on Wednesday.

U.S. lawmakers threaten to subpoena Trump aide Conway
U.S. lawmakers threaten to subpoena Trump aide Conway
  • US
  • 2019-06-24 01:46:18Z

A U.S. House of Representatives panel warned in a letter it could subpoena the testimony of Kellyanne Conway, a senior adviser to President Donald Trump, if she does not appear at a scheduled hearing this week. The House Oversight Committee, chaired by Democrat Elijah Cummings, said it would vote on a potential subpoena if Conway does not testify before lawmakers at a scheduled Wednesday session focused on her alleged violations of the Hatch Act. The hearing was scheduled after the Office of Special Counsel, a U.S. government watchdog agency, earlier this month recommended Conway be fired for repeatedly violating the Hatch Act by disparaging Democratic presidential candidates while...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: BioTech

Hit "Like"
Don't miss any important news
Thanks, you don't need to show me this anymore.